Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026)
Johnson & Johnson (JNJ) posted Exchange Rate Effect of $5.0 million for Q2 2026, up 120.0% sequentially from -$25.0 million in Q1 2026, and down 96.75% YoY from $154.0 million in Q2 2025.
Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Johnson & Johnson has reported Exchange Rate Effect for 18 years, with the latest figure at $5.0 million in Q2 2026.
- Quarterly Exchange Rate Effect fell 96.75% year-over-year to $5.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$43.0 million (down 129.66% YoY) and the FY2025 annual result came in at $201.0 million, up 169.55% from the prior year.
- Exchange Rate Effect improved to $5.0 million in Q2 2026 per JNJ's latest filing, from -$25.0 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $154.0 million in Q2 2025 and troughed at -$198.0 million in Q4 2024.
- A 5-year average of -$24.4 million and a median of -$10.0 million in 2026 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect sank 546.43% in 2024, then soared 281.18% in 2025.
- Over 5 years, Exchange Rate Effect stood at $16.0 million in 2022, then soared by 681.25% to $125.0 million in 2023, then slumped by 258.4% to -$198.0 million in 2024, then soared by 111.62% to $23.0 million in 2025, then sank by 78.26% to $5.0 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $5.0 million, -$25.0 million, and $23.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.04 Bn | 633.28 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 470.61 Bn | 464.04 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 379.00 Bn | 371.86 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 303.30 Bn | 295.61 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Astrazeneca | 258.47 Bn | 253.57 Bn | 12.86 Bn | 9.00 Mn |
| 6 | Amgen | 237.78 Bn | 223.79 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 183.75 Bn | 180.57 Bn | 6.22 Bn | -19.00 Mn |
| 8 | Pfizer | 160.91 Bn | 149.21 Bn | 10.94 Bn | -4.00 Mn |
| 9 | Gsk | 106.07 Bn | 101.90 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.31 Bn | 47.93 Bn | 10.79 Bn | 11.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 5.00 Mn |
| Jun 28, 2026 | 5.00 Mn |
| Mar 29, 2026 | -25.00 Mn |
| Mar 29, 2026 | -25.00 Mn |
| Dec 28, 2025 | 23.00 Mn |
| Dec 28, 2025 | 23.00 Mn |
| Sep 28, 2025 | -46.00 Mn |
| Sep 28, 2025 | -46.00 Mn |
| Jun 29, 2025 | 154.00 Mn |
| Jun 29, 2025 | 154.00 Mn |
| Mar 30, 2025 | 70.00 Mn |
| Mar 30, 2025 | 70.00 Mn |
| Dec 29, 2024 | -198.00 Mn |
| Dec 29, 2024 | -198.00 Mn |
| Sep 29, 2024 | 119.00 Mn |
| Sep 29, 2024 | 119.00 Mn |
| Jun 30, 2024 | -85.00 Mn |
| Jun 30, 2024 | -85.00 Mn |
| Mar 31, 2024 | -125.00 Mn |
| Mar 31, 2024 | -125.00 Mn |